These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 10465691

  • 1. Drug-induced parkinsonism: cinnarizine and flunarizine are potent uncouplers of the vacuolar H+-ATPase in catecholamine storage vesicles.
    Terland O, Flatmark T.
    Neuropharmacology; 1999 Jun; 38(6):879-82. PubMed ID: 10465691
    [Abstract] [Full Text] [Related]

  • 2. Possible pharmacokinetic and pharmacodynamic factors affecting parkinsonism inducement by cinnarizine and flunarizine.
    Kariya S, Isozaki S, Masubuchi Y, Suzuki T, Narimatsu S.
    Biochem Pharmacol; 1995 Nov 09; 50(10):1645-50. PubMed ID: 7503767
    [Abstract] [Full Text] [Related]

  • 3. Dopamine oxidation generates an oxidative stress mediated by dopamine semiquinone and unrelated to reactive oxygen species.
    Terland O, Flatmark T, Tangerås A, Grønberg M.
    J Mol Cell Cardiol; 1997 Jun 09; 29(6):1731-8. PubMed ID: 9220358
    [Abstract] [Full Text] [Related]

  • 4. The effect of calcium channel blockers on the H(+)-ATPase and bioenergetics of catecholamine storage vesicles.
    Terland O, Grønberg M, Flatmark T.
    Eur J Pharmacol; 1991 May 25; 207(1):37-41. PubMed ID: 1833213
    [Abstract] [Full Text] [Related]

  • 5. Aggravation of Parkinson's disease by cinnarizine.
    Fernandez Pardal M, Fernandez Pardal J, Micheli F.
    J Neurol Neurosurg Psychiatry; 1988 Jan 25; 51(1):158-9. PubMed ID: 3351524
    [No Abstract] [Full Text] [Related]

  • 6. Anticonvulsive properties of cinnarizine and flunarizine in rats and mice.
    Desmedt LK, Niemegeers CJ, Janssen PA.
    Arzneimittelforschung; 1975 Sep 25; 25(9):1408-13. PubMed ID: 1242663
    [Abstract] [Full Text] [Related]

  • 7. Flunarizine and cinnarizine-induced parkinsonism: a historical and clinical analysis.
    Teive HA, Troiano AR, Germiniani FM, Werneck LC.
    Parkinsonism Relat Disord; 2004 Jun 25; 10(4):243-5. PubMed ID: 15120099
    [Abstract] [Full Text] [Related]

  • 8. Flunarizine and cinnarizine inhibit mitochondrial complexes I and II: possible implication for parkinsonism.
    Veitch K, Hue L.
    Mol Pharmacol; 1994 Jan 25; 45(1):158-63. PubMed ID: 8302275
    [Abstract] [Full Text] [Related]

  • 9. The effect of prenylamine and organic nitrates on the bioenergetics of bovine catecholamine storage vesicles.
    Grønberg M, Terland O, Husebye ES, Flatmark T.
    Biochem Pharmacol; 1990 Jul 15; 40(2):351-5. PubMed ID: 2142883
    [Abstract] [Full Text] [Related]

  • 10. Omeprazole and bafilomycin, two proton pump inhibitors: differentiation of their effects on gastric, kidney and bone H(+)-translocating ATPases.
    Mattsson JP, Väänänen K, Wallmark B, Lorentzon P.
    Biochim Biophys Acta; 1991 Jun 18; 1065(2):261-8. PubMed ID: 1647821
    [Abstract] [Full Text] [Related]

  • 11. Studies on Mg2+-dependent ATPase in bovine adrenal chromaffin granules. With special reference to the effect of inhibitors and energy coupling.
    Grønberg M, Flatmark T.
    Eur J Biochem; 1987 Apr 01; 164(1):1-8. PubMed ID: 2881784
    [Abstract] [Full Text] [Related]

  • 12. Permanent non-progressive cinnarizine and flunarizine-induced parkinsonism: An under-recognized tardive syndrome in the elderly?
    Calzetti S, Negrotti A.
    J Neurol Sci; 2023 Jan 15; 444():120526. PubMed ID: 36584558
    [Abstract] [Full Text] [Related]

  • 13. Partial purification and characterization of the vacuolar H(+)-ATPase of mammalian synaptic vesicles.
    Floor E, Leventhal PS, Schaeffer SF.
    J Neurochem; 1990 Nov 15; 55(5):1663-70. PubMed ID: 2145397
    [Abstract] [Full Text] [Related]

  • 14. Energy coupling of L-glutamate transport and vacuolar H(+)-ATPase in brain synaptic vesicles.
    Moriyama Y, Maeda M, Futai M.
    J Biochem; 1990 Oct 15; 108(4):689-93. PubMed ID: 2149857
    [Abstract] [Full Text] [Related]

  • 15. Flunarizine- and cinnarizine-induced extrapyramidal reactions.
    Micheli F, Pardal MF, Gatto M, Torres M, Paradiso G, Parera IC, Giannaula R.
    Neurology; 1987 May 15; 37(5):881-4. PubMed ID: 3574697
    [Abstract] [Full Text] [Related]

  • 16. A long-term follow-up study of cinnarizine- and flunarizine-induced parkinsonism.
    Negrotti A, Calzetti S.
    Mov Disord; 1997 Jan 15; 12(1):107-10. PubMed ID: 8990063
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Uptake of the neurotoxin, 4-methylphenylpyridinium, into chromaffin granules and synaptic vesicles: a proton gradient drives its uptake through monoamine transporter.
    Moriyama Y, Amakatsu K, Futai M.
    Arch Biochem Biophys; 1993 Sep 15; 305(2):271-7. PubMed ID: 8373164
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of glutamate uptake and proton pumping in synaptic vesicles by S-nitrosylation.
    Wolosker H, Reis M, Assreuy J, de Meis L.
    J Neurochem; 1996 May 15; 66(5):1943-8. PubMed ID: 8780021
    [Abstract] [Full Text] [Related]

  • 20. Oxidative metabolism of flunarizine and cinnarizine by microsomes from B-lymphoblastoid cell lines expressing human cytochrome P450 enzymes.
    Kariya S, Isozaki S, Uchino K, Suzuki T, Narimatsu S.
    Biol Pharm Bull; 1996 Nov 15; 19(11):1511-4. PubMed ID: 8951176
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.